Richard MacIsaac

Prof Richard MacIsaac

Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne
Richard MacIsaac is professor and director of Endocrinology and Diabetes at St Vincent’s Hospital Melbourne and the University of Melbourne. Prior to taking up his current position he was head of diabetes at Austin Health, Melbourne. His main research interest is diabetes and its complications, especially those related to cardiovascular and kidney disease. He has published over 180 research articles. Prior to embarking in a career in medicine, he completed a PhD at the Howard Florey Institute, Melbourne where he examined the development of the foetal hypothalamic-pituitary-adrenal axis and then embarked on a 2-year post doctorial fellowship at St Vincent’s Institute of Medical Research, Melbourne examining foetal calcium metabolism. He graduated from the University of Melbourne’s Medical School in 1995 and was awarded his fellowship with the Royal Australasian College of Physicians in 2002. Currently specific research interests are inpatient glycaemic control, defining the albuminuria and glomerular filtration rate relationship in diabetes, investigating new biomarkers for renal and vascular disease in diabetes and studying renal function in indigenous Australians.

More from this expert

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Podcasts iconPodcasts

Hear about why urine ACR is critical, the hidden risks of CKD Stage 3A, and how new therapies like SGLT2 inhibitors and GLP-1 receptor agonists are changing care - even beyond diabetes.

Podcasts iconPodcasts

In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Videos iconVideos

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.